|Day Low/High||19.17 / 20.22|
|52 Wk Low/High||11.01 / 18.44|
Cramer will be monitoring earnings and the Federal Reserve next week.
In recent trading, shares of LeMaitre Vascular Inc have crossed above the average analyst 12-month target price of $18.70, changing hands for $20.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Looking at the universe of stocks we cover at Dividend Channel, on 8/18/16, LeMaitre Vascular Inc will trade ex-dividend, for its quarterly dividend of $0.045, payable on 9/6/16. As a percentage of LMAT's recent stock price of $17.33, this dividend works out to approximately 0.26%.
- $5.0mm Share Repurchase -
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Looking at the universe of stocks we cover at Dividend Channel, on 3/17/16, LeMaitre Vascular Inc will trade ex-dividend, for its quarterly dividend of $0.045, payable on 4/4/16. As a percentage of LMAT's recent stock price of $14.66, this dividend works out to approximately 0.31%.
Stocks with insider trader activity include HIL, PCRX and LMAT
Trade-Ideas LLC identified LeMaitre Vascular (LMAT) as a strong on high relative volume candidate
Which health care stocks are both alluring - when it comes to rapid advances in new technology or a cure for a disease - but also sound investments?